...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Effect of a Short Course of Prednisolone in Infants With Oxygen-Dependent Bronchopulmonary Dysplasia
【24h】

Effect of a Short Course of Prednisolone in Infants With Oxygen-Dependent Bronchopulmonary Dysplasia

机译:短期泼尼松龙对氧依赖性支气管肺发育不良的婴儿的影响

获取原文
           

摘要

OBJECTIVE. The purpose of this work was to determine whether oral prednisolone is effective in weaning infants with bronchopulmonary dysplasia, after 36 weeks' postmenstrual age, off supplemental oxygen and to identify factors associated with successful weaning.METHODS. Data were abstracted from a standardized prospectively collected database at the John Dempsey Hospital NICU. Logistic regression and receiver operating curve analyses were used.RESULTS. Of 385 infants, 131 (34%) received oral prednisolone and 254 (66%) did not. There was no significant difference in race, gender, birth weight, or gestational age between the groups receiving and not receiving oral prednisolone. Infants in the oral prednisolone group were more likely to have received previous dexamethasone therapy, had longer duration of mechanical ventilation, had longer length of hospital stay, and were more likely to be discharged from the hospital on oxygen. Of those in the oral prednisolone group, 63% responded to treatment. Pulmonary acuity score and Pco2 were the only parameters that remained significant on multiple logistic regression analyses. The oral prednisolone-responsive group had a lower pulmonary acuity score compared with the oral prednisolone-nonresponsive group. A pulmonary acuity score value of ≤0.5 had a sensitivity of 20% and specificity of 97.4%, with positive and negative predictive values of 94.1% and 42.1%, respectively. Capillary Pco2 values were significantly lower in the oral prednisolone-responsive group compared with the oral prednisolone-nonresponsive group. In predicting a successful response to oral prednisolone, a capillary Pco2 value of 48.5 mmHg had a sensitivity of 50% and specificity of 89.7%, with positive and negative predictive values of 89.1% and 51.8%, respectively.CONCLUSIONS. Oral prednisolone therapy is effective in weaning off supplemental oxygen in a postterm infant with oxygen-dependent bronchopulmonary dysplasia who has a pulmonary acuity score of 0.5 and Pco2 of 48.5 mmHg. In addition, if a single course of prednisolone fails, there is no clear benefit of using multiple courses.
机译:目的。这项工作的目的是确定月经后36周龄,补充氧气后口服泼尼松龙是否对支气管肺发育不良的断奶婴儿有效,并确定与成功断奶有关的因素。数据是从John Dempsey Hospital NICU的标准化前瞻性收集数据库中提取的。使用Logistic回归和接收器工作曲线分析。在385名婴儿中,有131名(34%)接受口服泼尼松龙,而254名(66%)未接受口服泼尼松龙。接受和不接受口服泼尼松龙的人群在种族,性别,出生体重或胎龄方面无显着差异。口服泼尼松龙组的婴儿更可能接受过先前的地塞米松治疗,机械通气时间更长,住院时间更长,并且更有可能因氧气而出院。在口服泼尼松龙组中,有63%对治疗有反应。肺敏锐度评分和Pco2是唯一在多项logistic回归分析中仍然有意义的参数。与口服泼尼松龙无反应组相比,口服泼尼松龙反应组的肺敏度评分较低。 ≤0.5的肺敏度得分敏感性为20%,特异性为97.4%,阳性和阴性预测值分别为94.1%和42.1%。与口服泼尼松龙无反应组相比,口服泼尼松龙反应组的毛细血管Pco2值显着降低。在预测对口服泼尼松龙的成功反应中,毛细血管Pco2值<48.5 mmHg的敏感性为50%,特异性为89.7%,阳性和阴性的预测值分别为89.1%和51.8%。口服泼尼松龙疗法可有效治疗肺敏度<0.5,Pco2 <48.5 mmHg的氧依赖型支气管肺发育不良的足月儿断奶补充氧气。另外,如果泼尼松龙的一个疗程失败,则使用多个疗程没有明显的好处。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号